MENU
CCCC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
C4 Therapeutics (CCCC) Ownership - Who owns C4 Therapeutics?
Profile
Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
145
Web
https://www.c4therapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
304.24M
P/E Ratio
N/A
Total Cash
255.64M
Projected Growth
N/A
Total Debt
67.1M
Revenue
33.67M
Risk (Beta)
3.61
Dividend Yield
N/A
Total Cash/Share
3.62
Total Debt/Equity
N/A
Revenue/Share
0.52 USD as % of share price
Fundamentals
CCCC
Capitalization
304M
P/E Ratio
N/A
Risk (Beta)
3.61
Dividend Yield
N/A
Total Cash
256M
Total Cash/Share
3.62
Total Debt
67.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.52%
Revenue
33.7M
ROE
N/A
Book Value
243M
P/B Ratio
1.18
Cash Flow
N/A
Earnings
-1.71
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
6.31
Current Revenue Per Employee
105944.83
Dividends Per Share - Security
N/A
EBITDA
-103.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.76
Shares Held By Institutions
354M
Shares Outstanding - Current
70.6M
Total Liabilities
133M
Total Volume MTD
N/A
Value
1
Gain YTD
-28.319
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
145
Web
https://www.c4therapeutics.com